FDA Approves ACYCLOVIR — Westminster Pharmaceuticals, LLC

Westminster Pharmaceuticals, LLC received FDA approval on March 7, 2018, for the Abbreviated New Drug Application (ANDA) #210401 for the oral version of the antiviral drug acyclovir. Following this regulatory clearance, the company is poised to enter the market with a generic alternative, which is expected to intensify competitive pricing in this established antiviral segment.